Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.13
+0.13 (2.60%)
Mar 3, 2026, 1:29 PM EST - Market open
Immuneering Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$17.20
Upside
+235.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +289.86% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $15 | Buy | Initiates | $15 | +192.40% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +114.42% | Sep 30, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 → $20 | Strong Buy | Maintains | $13 → $20 | +289.86% | Sep 26, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $21 → $30 | Buy | Maintains | $21 → $30 | +484.80% | Sep 25, 2025 |
| Needham | Needham | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +114.42% | Sep 15, 2025 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +55.95% | Aug 26, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +153.41% | Aug 14, 2025 |
| Mizuho | Mizuho | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +94.93% | Jun 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +75.44% | Jun 18, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +153.41% | Jun 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +75.44% | Jun 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $21 | Buy | Maintains | $25 → $21 | +309.36% | May 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +153.41% | May 6, 2025 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +133.92% | Apr 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +153.41% | Mar 24, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.